CMS criticized over lack of support for CT colonography

Imaging societies and advocacy groups nearly universally decried CMS’s decision to not revisit Medicare coverage for CT colonography (CTC). CTC has endorsements from major players including the American Cancer Society, American College of Radiology (ACR) and the U.S. Food and Drug Administration.

It’s required to be insured in 33 states and Washington, D.C., and even the U.S. Preventative Services Task Force (USPSTF) gives the exam an “A” rating, prompting questions about the lack of Medicare coverage.

“The Centers for Medicare & Medicaid Services’ (CMS) decision not to re-examine Medicare coverage for CT colonography (CTC) is out of step with modern medicine and the needs of America’s seniors. Abundant efficacy and cost-effectiveness evidence demonstrates that CTC (also known as virtual colonoscopy) is a front line colorectal cancer (CRC) screening tool,” the ACR said in a statement. “Medicare patients who need this life saving screening the most are denied coverage. This must change if we are to attract the up to 40 percent of Americans who should be screened for CRC, but choose not to, to get tested. Lives are being lost every day that Medicare coverage is denied.”

While the low patient acceptance of traditional colonoscopy is a separate problem, CTC doesn’t involve a six-foot long scope in the rectum, translating to patients who are much more willing to undergo the screening.

The recent approval of a DNA stool test by CMS shows an inconsistency in the criteria used, according to the ACR.

CTC detects colorectal cancer and precancerous polyps far better than the DNA stool test, is more cost effective, and results in fewer false positive results—results that still prompt a traditional colonoscopy.

“The ACR will work closely with CMS to resolve any issues that they may still have about CTC. The College will also continue to work with the colorectal cancer care advocacy groups, patients, lawmakers and other decision makers to secure Medicare coverage for CT colonography.” said the ACR.

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.